| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2020 | Hidalgo-Sastre A, Lubeseder-Martellato C, Engleitner T, Steiger K, Zhong S, Desztics J, Öllinger R, Rad R, Schmid RM, Hermeking H, Siveke JT, von Figura G. Mir34a constrains pancreatic carcinogenesis. Scientific Reports. 10: 9654. PMID 32541781 DOI: 10.1038/s41598-020-66561-1 | 0.324 | |||
| 2020 | Kaissis GA, Ziegelmayer S, Lohöfer FK, Harder FN, Jungmann F, Sasse D, Muckenhuber A, Yen HY, Steiger K, Siveke J, Friess H, Schmid R, Weichert W, Makowski MR, Braren RF. Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma. Journal of Clinical Medicine. 9. PMID 32155990 DOI: 10.3390/Jcm9030724 | 0.309 | |||
| 2019 | Walter K, Tiwary K, Trajkovic-Arsic M, Hidalgo-Sastre A, Dierichs L, Liffers ST, Gu J, Gout J, Schulte LA, Münch J, Seufferlein T, Sainz B, Siveke JT, Rodriguez-Aznar E, Hermann PC. MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells and . Stem Cells International. 2019: 8475389. PMID 31281387 DOI: 10.1155/2019/8475389 | 0.347 | |||
| 2019 | Horak P, Heining C, Kreutzfeldt S, Heilig CE, Möhrmann L, Gieldon L, Fröhlich M, Uhrig S, Hübschmann D, Beck K, Richter D, Wolf S, Pfütze K, Geörg C, Meißburger B, ... ... Siveke J, et al. Abstract 468: Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies: Results from the MASTER trial of the German Cancer Consortium Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-468 | 0.315 | |||
| 2018 | Lee K, Bodoky G, Blanc J, Siveke J, Mercadé TM, Wang-Gillam A, Chen L, Mirakhur B, Chen J, de Jong F. Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: v42-v43. PMID 32177133 DOI: 10.1093/Annonc/Mdy151.152 | 0.324 | |||
| 2018 | Lakatos G, Lee K, Siveke J, Blanc J, Mercadé TM, Dean A, Bodoky G, Mirakhur B, Chen J, Wang-Gillam A, Chen L, de Jong F. Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: v42. PMID 32177132 DOI: 10.1093/Annonc/Mdy151.150 | 0.305 | |||
| 2018 | Mercadé TM, Wang-Gillam A, Chen L, Blanc J, Lee K, Bodoky G, Dean A, Siveke J, Mirakhur B, Chen J, de Jong F. Prognostic effect of primary tumor location in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: v41-v42. PMID 32177128 DOI: 10.1093/Annonc/Mdy151.149 | 0.327 | |||
| 2018 | Behrens D, Büttner B, Lawlor RL, Heeschen C, Buchholz M, Siveke J, Wengner AM, Saluja A, Hoffmann J. Abstract 4093: Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2018-4093 | 0.374 | |||
| 2017 | Schultheis B, Reuter D, Ebert MP, Siveke J, Kerkhoff A, Berdel WE, Hofheinz R, Behringer DM, Schmidt WE, Goker E, De Dosso S, Kneba M, Yalcin S, Overkamp F, Schlegel F, et al. Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 2429-2435. PMID 28961832 DOI: 10.1093/Annonc/Mdx343 | 0.341 | |||
| 2017 | Chen NM, Neesse A, Dyck ML, Steuber B, Koenig AO, Lubeseder-Martellato C, Winter T, Forster T, Bohnenberger H, Kitz J, Jessen KR, Griesmann H, Gaedcke J, Grade M, Zhang JS, ... ... Siveke J, et al. Context-dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity. Gastroenterology. PMID 28188746 DOI: 10.1053/J.Gastro.2017.01.043 | 0.383 | |||
| 2017 | Dantes Z, Wirth M, Feldmann K, Nomura A, Muckenhuber A, Steiger K, Strobel O, martignoni M, Ceyhan G, Siveke J, Delius Sv, Weichert W, Braren R, Rustgi AK, Schmid R, et al. A Novel Predictive Organoid Culture System from Pancreatic Cancer Patients - Personalized Medicine in Realtime Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)30433-X | 0.327 | |||
| 2016 | Ma X, Phi Van V, Kimm MA, Prakash J, Kessler H, Kosanke K, Feuchtinger A, Aichler M, Gupta A, Rummeny EJ, Eisenblätter M, Siveke J, Walch AK, Braren R, Ntziachristos V, et al. Integrin-Targeted hybrid Fluorescence Molecular Tomography/X-ray Computed Tomography for Imaging Tumor Progression and Early Response in Non-Small Cell Lung Cancer. Neoplasia (New York, N.Y.). 19: 8-16. PMID 27940248 DOI: 10.1016/J.Neo.2016.11.009 | 0.348 | |||
| 2016 | Wang-Gillam A, Von Hoff D, Siveke J, Hubner R, Belanger B, Pipas JM, Chen LT. Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016701607. PMID 27918719 DOI: 10.1200/Jco.2016.70.1607 | 0.312 | |||
| 2016 | Hidalgo-Sastre A, Brodylo RL, Lubeseder-Martellato C, Sipos B, Steiger K, Lee M, von Figura G, Grünwald B, Zhong S, Trajkovic-Arsic M, Neff F, Schmid RM, Siveke JT. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. The American Journal of Pathology. PMID 27639167 DOI: 10.1016/j.ajpath.2016.07.025 | 0.369 | |||
| 2016 | Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, et al. Pancreatic Pre-malignant Lesions Secrete TIMP1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Pre-Metastatic Niche in the Liver. Gastroenterology. PMID 27506299 DOI: 10.1053/J.Gastro.2016.07.043 | 0.375 | |||
| 2016 | Löhr M, Stecker K, Huelsewig C, Morandell S, Ertongur I, Luke-Glaser S, Laib A, Malgerud L, Moro CF, Karimi M, Permert J, Heuchel R, Lindberg J, Wirta V, Picker A, ... ... Siveke J, et al. Abstract 3165: An evidence-based software tool for personalized cancer medicine to recommend therapeutic options and avoid toxicity Cancer Research. 76: 3165-3165. DOI: 10.1158/1538-7445.Am2016-3165 | 0.353 | |||
| 2016 | Hessmann E, Chen N, Lubeseder-Martellato C, Gaedcke J, Siveke J, Neesse A, Ellenrieder V. Context-dependent epigenetic regulation of NFATc1 transcription in pancreatic plasticity Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.040 | 0.331 | |||
| 2015 | Vogel A, Kullmann F, Kunzmann V, Al-Batran SE, Oettle H, Plentz R, Siveke J, Springfeld C, Riess H. Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine. Oncology Research and Treatment. 38: 596-603. PMID 26599274 DOI: 10.1159/000441310 | 0.336 | |||
| 2015 | Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke JT, Rad R, Schmid RM, Saur D, Rustgi AK, Reichert M, Schneider G. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. PMID 26592448 DOI: 10.1038/Onc.2015.437 | 0.303 | |||
| 2015 | Duewell P, Beller E, Kirchleitner SV, Adunka T, Bourhis H, Siveke J, Mayr D, Kobold S, Endres S, Schnurr M. Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma. Oncoimmunology. 4: e1029698. PMID 26504669 DOI: 10.1080/2162402X.2015.1029698 | 0.393 | |||
| 2015 | Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, ... ... Siveke JT, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nature Medicine. PMID 26390243 DOI: 10.1038/Nm.3952 | 0.704 | |||
| 2015 | Kleeff J, Michalski C, Kong B, Erkan M, Roth S, Siveke J, Friess H, Esposito I. Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience. Hpb Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery. 2015: 847837. PMID 25873753 DOI: 10.1155/2015/847837 | 0.318 | |||
| 2015 | Mazur PK, Herner A, Neff F, Siveke JT. Current methods in mouse models of pancreatic cancer. Methods in Molecular Biology (Clifton, N.J.). 1267: 185-215. PMID 25636470 DOI: 10.1007/978-1-4939-2297-0_9 | 0.649 | |||
| 2015 | Chen NM, Singh G, Koenig A, Liou GY, Storz P, Zhang JS, Regul L, Nagarajan S, Kühnemuth B, Johnsen SA, Hebrok M, Siveke J, Billadeau DD, Ellenrieder V, Hessmann E. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. Gastroenterology. 148: 1024-1034.e9. PMID 25623042 DOI: 10.1053/J.Gastro.2015.01.033 | 0.393 | |||
| 2015 | Singh SK, Chen NM, Hessmann E, Siveke J, Lahmann M, Singh G, Voelker N, Vogt S, Esposito I, Schmidt A, Brendel C, Stiewe T, Gaedcke J, Mernberger M, Crawford HC, et al. Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. The Embo Journal. 34: 517-30. PMID 25586376 DOI: 10.15252/Embj.201489574 | 0.427 | |||
| 2015 | Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model. Oncogene. 34: 578-88. PMID 24509876 DOI: 10.1038/Onc.2013.592 | 0.624 | |||
| 2015 | Gupta A, Trajkovic-Arsic M, Heid I, Teichman N, Kalederis E, Braren R, Siveke J. Abstract B141: Predictive value of genetically engineered endogenous mouse models in preclinical therapeutic studies Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B141 | 0.403 | |||
| 2015 | Kamyabi-Moghaddam Z, Reichert M, Schmid R, Siveke J. Isolation and Expansion of Pancreatic Cancer Cells for Molecular and Functional Analysis Zeitschrift Fur Gastroenterologie. 53. DOI: 10.1055/S-0035-1559090 | 0.37 | |||
| 2015 | Trajkovic-Arsic M, Heid I, Steiger K, Gupta A, Fingerle A, Wörner C, Teichmann N, Wenzel P, Herner A, Steingötter A, Beer A, Schweiger M, Settles M, Haller B, Esposito I, ... ... Siveke J, et al. Evaluation of Diffusion-weighted magnetic resonance imaging for therapy response in pancreatic cancer in mouse models Zeitschrift Fur Gastroenterologie. 53. DOI: 10.1055/S-0035-1559088 | 0.31 | |||
| 2014 | Kleeff J, Kong B, Siveke J, Esposito I. Re: proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. Journal of the National Cancer Institute. 106. PMID 25359853 DOI: 10.1093/Jnci/Dju263 | 0.398 | |||
| 2014 | Siveke JT. The increasing diversity of KRAS signaling in pancreatic cancer. Gastroenterology. 147: 736-9. PMID 25167989 DOI: 10.1053/j.gastro.2014.08.026 | 0.321 | |||
| 2014 | Baumgart S, Chen NM, Siveke JT, König A, Zhang JS, Singh SK, Wolf E, Bartkuhn M, Esposito I, Heßmann E, Reinecke J, Nikorowitsch J, Brunner M, Singh G, Fernandez-Zapico ME, et al. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Cancer Discovery. 4: 688-701. PMID 24694735 DOI: 10.1158/2159-8290.Cd-13-0593 | 0.334 | |||
| 2014 | Von Hoff D, Li C, Wang-Gillam A, Bodoky G, Dean A, Jameson G, Macarulla T, Lee K, Cunningham D, Blanc J, Hubner R, Chiu C, Schwartsmann G, Siveke J, Braiteh F, et al. NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy Annals of Oncology. 25: ii105. DOI: 10.1093/Annonc/Mdu193.3 | 0.368 | |||
| 2013 | Boeck S, Siveke J, Ormanns S, Laubender R, Jung A, Haas M, Vehling-Kaiser U, Winkelmann C, Weikersthal LFv, Clemens M, Gauler T, Märten A, Klein S, Kojouharoff G, Geissler M, et al. O-0003P-Erk, P-Akt And P53 As Tissue Biomarkers In Erlotinib-Treated Patients With Advanced Pancreatic Cancer: A Translational Subgroup Analysis From Aio-Pk0104 Annals of Oncology. 24. DOI: 10.1093/Annonc/Mdt201.3 | 0.302 | |||
| 2013 | Glesel E, Chen N, Dyck M, Geisel B, Reutlinger K, Siveke J, Gress T, Ellenrieder V. Regeneration from acute pancreatitis requires transcriptional silencing of NFATc1 Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1352846 | 0.403 | |||
| 2013 | Kalideris E, Grüner B, Trajkovic-Arsic M, Mazur P, Schmid R, Siveke J. The role of insulin receptor and insulin-like growth factor I receptor in pancreatic ductal adenocarcinoma Zeitschrift Fur Gastroenterologie. 51. DOI: 10.1055/S-0033-1352845 | 0.61 | |||
| 2013 | Trajkovic-Arsic M, Heid I, Esposito I, Steiger K, Teichmann N, Steingötter A, Menne D, Scholz A, Rummeny E, Siveke J, Braren R. ADC as therapy response marker for pancreatic ductal adenocarcinoma in genetically engineered mice Rofo-Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 185. DOI: 10.1055/S-0033-1346234 | 0.34 | |||
| 2013 | Trajkovic-Arsic M, Sarantopoulos A, Themelis G, Kalideris E, Beer A, Pohle K, Wester J, Schmid R, Ntziachristos V, Braren R, Siveke J. Molecular imaging of integrin avb3 for in vivo detection of precursor lesions and pancreatic cancer in mice RöFo - Fortschritte Auf Dem Gebiet Der RöNtgenstrahlen Und Der Bildgebenden Verfahren. 185. DOI: 10.1055/S-0033-1346206 | 0.39 | |||
| 2013 | Jeliazkova P, Jörs S, Lee M, Zimber-Strobl U, Ferrer J, Schmid R, Siveke J, Geisler F. Notch2 converts hepatoblasts and adult hepatocytes to the biliary lineage via canonical Notch signalling independent of Hes1 in mice Zeitschrift Fur Gastroenterologie. 51. DOI: 10.1055/S-0032-1331900 | 0.339 | |||
| 2013 | Chen NM, Hessmann E, Baumgart S, Singh SK, Singh G, Reutlinger K, Lubeseder C, Siveke J, Gress TM, Ellenrieder V. Regeneration from acute pancreatitis requires transcriptional silencing of NFATc1 Pancreatology. 13. DOI: 10.1016/J.Pan.2013.04.315 | 0.331 | |||
| 2013 | Baumgart S, Chen N, Brunner M, Johanna R, Nikorowitsch J, Singh S, König A, Zhang J, Wolf E, Bartkuhn M, Siveke J, Esposito I, Glesel E, Geisel B, Reutlinger K, et al. Nuclear factor of activated T-cells c1 integrates STAT3 signals to link chronic inflammation and carcinogenesis in the pancreas Pancreatology. 13: S16. DOI: 10.1016/J.Pan.2013.04.047 | 0.486 | |||
| 2012 | Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, ... ... Siveke JT, et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22: 304-17. PMID 22975374 DOI: 10.1016/J.Ccr.2012.07.024 | 0.638 | |||
| 2012 | Grüner BM, Hahne H, Mazur PK, Trajkovic-Arsic M, Maier S, Esposito I, Kalideris E, Michalski CW, Kleeff J, Rauser S, Schmid RM, Küster B, Walch A, Siveke JT. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. Plos One. 7: e39424. PMID 22761793 DOI: 10.1371/Journal.Pone.0039424 | 0.631 | |||
| 2012 | Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. The Journal of Pathology. 226: 723-34. PMID 21984419 DOI: 10.1002/Path.3017 | 0.686 | |||
| 2012 | Mazur PK, Riener MO, Jochum W, Kristiansen G, Weber A, Schmid RM, Siveke JT. Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. The American Journal of Gastroenterology. 107: 126-35. PMID 21931375 DOI: 10.1038/Ajg.2011.305 | 0.646 | |||
| 2012 | Mazur PK, Siveke JT. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology. Gut. 61: 1488-500. PMID 21873467 DOI: 10.1136/Gutjnl-2011-300756 | 0.65 | |||
| 2012 | Halbrook CJ, Takeuchi KK, Ardito CM, Gruener BM, Siveke JT, Crawford HC. Abstract B84: EGFR activation by the ADAM17 sheddase is required for Kras-induced pancreatic tumorigenesis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B84 | 0.323 | |||
| 2012 | Mazur PK, Lubeseder-Martellato C, Grüner BM, Sipos B, Angelis MHd, Sage J, Schmid RM, Siveke JT. Abstract A55: Dual role of the Notch ligand Delta-1 in pancreatic carcinogenesis and metastasis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A55 | 0.75 | |||
| 2012 | Baumgart S, Chen N, Reinecke J, Klindt C, Nikorowitsch J, Singh S, Zhang J, Wolf E, Bartkuhn M, Griesmann H, Siveke J, Esposito I, Geisel B, Reutlinger K, Singh G, et al. Nuclear NFATc1 integrates STAT3 signaling to promote Kras-driven pancreatic carcinogenesis Pancreatology. 12: 548-549. DOI: 10.1016/J.Pan.2012.11.161 | 0.388 | |||
| 2011 | Heid I, Lubeseder-Martellato C, Sipos B, Mazur PK, Lesina M, Schmid RM, Siveke JT. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology. 141: 719-30, 730.e1-7. PMID 21684285 DOI: 10.1053/J.Gastro.2011.04.043 | 0.672 | |||
| 2011 | Mazur PK, Lubeseder-Martellato C, Grüner BM, Kaznowska E, Sipos B, Angelis MHd, Schmid RM, Sage J, Siveke JT. Abstract PR16: Important bidirectional function in the Notch-Delta signaling in pancreatic carcinogenesis and metastasis Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-Pr16 | 0.752 | |||
| 2011 | Grüner BM, Lubeseder-Martellato C, Briel T, Mazur PK, Schmid RM, Siveke JT. Abstract PR11: Egfr is essential for Ras-driven pancreatic cancer development Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-Pr11 | 0.666 | |||
| 2011 | Trajkovic-Arsic M, Sarantopoulos A, Themelis G, Kalideris E, Braren R, Ntziachristos V, Siveke J. Abstract C14: Optical imaging of integrin αVβ3 detects pancreatic cancer in endogenous mouse models. Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C14 | 0.386 | |||
| 2011 | Brodylo RL, Lee M, Lubeseder-Martellato C, Mazur PK, Hampel F, Zimber-Strobel U, Strobel LJ, Schmid RM, Siveke JT. Abstract A32: Notch pathway regulates pancreatic acinar-to-ductal metaplasia Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-A32 | 0.659 | |||
| 2010 | Mazur PK, Grüner BM, Nakhai H, Sipos B, Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM, Siveke JT. Identification of epidermal Pdx1 expression discloses different roles of Notch1 and Notch2 in murine Kras(G12D)-induced skin carcinogenesis in vivo. Plos One. 5: e13578. PMID 21042537 DOI: 10.1371/Journal.Pone.0013578 | 0.654 | |||
| 2010 | Mazur PK, Einwächter H, Lee M, Sipos B, Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G, Schmid RM, Siveke JT. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 107: 13438-43. PMID 20624967 DOI: 10.1073/Pnas.1002423107 | 0.712 | |||
| 2010 | Geisler F, Lee M, Krutsch S, Hampel F, Zimber-Strobl U, Strobl L, Schmid R, Siveke J. Notch2 reguliert Gallengangsspezifizierung und -morphogenese Zeitschrift Fur Gastroenterologie. 48: 605. DOI: 10.1055/S-0030-1264044 | 0.307 | |||
| 2010 | Grüner B, Hahne H, Trajkovic-Arsic M, Mazur P, Esposito I, Rauser S, Schmid R, Küster B, Walch A, Siveke J. In situ proteomic analysis of preneoplastic lesions in targeted mouse models of pancreatic cancer using MALDI imaging mass spectrometry Zeitschrift Fur Gastroenterologie. 48: 557. DOI: 10.1055/S-0030-1263997 | 0.654 | |||
| 2010 | Mazur P, Sipos B, Zimber-Strobl U, Strobl L, Radtke F, Schmid R, Siveke J. 858 Deficiency of Notch2 suppresses pancreatic carcinogenesis and Myc signaling in vivo European Journal of Cancer Supplements. 8: 216. DOI: 10.1016/S1359-6349(10)71652-9 | 0.664 | |||
| 2008 | Geisler F, Nagl F, Mazur PK, Lee M, Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM, Siveke JT. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology (Baltimore, Md.). 48: 607-16. PMID 18666240 DOI: 10.1002/Hep.22381 | 0.623 | |||
| 2008 | Nakhai H, Siveke JT, Klein B, Mendoza-Torres L, Mazur PK, Algül H, Radtke F, Strobl L, Zimber-Strobl U, Schmid RM. Conditional ablation of Notch signaling in pancreatic development. Development (Cambridge, England). 135: 2757-65. PMID 18635610 DOI: 10.1242/Dev.013722 | 0.682 | |||
| 2008 | Siveke JT, Lubeseder-Martellato C, Lee M, Mazur PK, Nakhai H, Radtke F, Schmid RM. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology. 134: 544-55. PMID 18242220 DOI: 10.1053/J.Gastro.2007.11.003 | 0.663 | |||
| 2008 | Siveke J, Mazur P, Sipos B, Nakhai H, Radtke F, Strobl L, Zimber-Strobl U, Klöppel G, Schmid R. Pancreas-specific ablation of Notch2 but not Notch1 compromises KrasG12D-induced PanIN progression and tumor development Zeitschrift Fur Gastroenterologie. 46. DOI: 10.1055/S-0028-1089536 | 0.644 | |||
| 2007 | Siveke JT, Einwächter H, Sipos B, Lubeseder-Martellato C, Klöppel G, Schmid RM. Concomitant Pancreatic Activation of KrasG12D and Tgfa Results in Cystic Papillary Neoplasms Reminiscent of Human IPMN Cancer Cell. 12: 266-279. PMID 17785207 DOI: 10.1016/j.ccr.2007.08.002 | 0.356 | |||
| 2005 | Siveke JT, Schmid RM. Chromosomal instability in mouse metastatic pancreatic cancer--it's Kras and Tp53 after all. Cancer Cell. 7: 405-7. PMID 15894260 DOI: 10.1016/J.CCR.2005.04.025 | 0.3 | |||
| 2005 | Schneider G, Saur D, Siveke J, Fritsch R, Schmid RM. IKK1 promotes G1 phase progression of pancreatic cancer cells by the transcriptional regulation of the F-box protein skp2 Zeitschrift Fur Gastroenterologie. 43: 335. DOI: 10.1055/S-2005-920118 | 0.344 | |||
| Show low-probability matches. | |||||